Amerant (AMTB) Q1 2026 earnings review
Earnings Rebound on Massive Cost Cuts, But Core Revenue Cracks
Amerant reported a sharp sequential rebound in Net Income to $17.9M ($0.44 EPS) from a disastrous $2.7M in 25Q4. However, the quality of these earnings is poor. The bottom-line beat was manufactured entirely by a 37% plunge in noninterest expenses as Q4's heavy restructuring charges faded. The actual core business is decelerating: Net Interest Income dropped 11% sequentially, and Net Interest Margin (NIM) compressed a severe 23 basis points to 3.55%. With management guiding for further NIM compression to 3.40%-3.50% in Q2, the bank is relying on a radical 'cost diet' to outrun a shrinking top line.
🐂 Bull Case
Management promised aggressive cost controls and delivered. Noninterest expense dropped ~$40M sequentially. The $66.9M Q1 print proves they can achieve their goal of operating under $70M per quarter.
Low-cost international deposits (averaging just 1.04% cost) reached $2.7B, largely fueled by relationships in Venezuela, offering a distinct structural funding advantage over domestic peers.
🐻 Bear Case
NIM fell from a peak of 3.92% in 25Q3 to 3.55% today, and is guided to drop further to ~3.45% next quarter. The core earnings power of the balance sheet is weakening rapidly.
Despite massive write-offs in prior quarters, Non-Performing Loans (NPLs) ticked up to $176.1M, and Special Mention loans increased 8.6% sequentially to $148.2M.
⚖️ Verdict: ⚪
Neutral. The transition to a leaner, more efficient bank is visually apparent in the EPS rebound, but you cannot shrink your way to long-term prosperity. Until NIM stabilizes and the credit cleanup concludes, the turnaround remains fragile.
Key Themes
Net Interest Margin in Freefall
NIM is decelerating aggressively. It dropped 23 bps in a single quarter (from 3.78% to 3.55%) and management expects it to fall further to the 3.40%-3.50% range in Q2. Total interest income on loans fell by $12.1M sequentially while the cost of domestic deposits barely budged (3.00% vs 2.96% in Q4).
Radical Cost Diet
The operational efficiency drive is the sole reason EPS beat the prior quarter. Noninterest expenses fell from $106.8M to $66.9M. Even factoring out Q4's non-core items, the $66.9M represents a solid baseline improvement. Salaries and benefits dropped 17% sequentially. Management expects to hold this line at ~$68M through the end of the year.
Brokered Deposits Resurge (Contradicting the Narrative)
In Q4 2025, management explicitly stated they were shrinking the balance sheet below $10B by purging high-cost wholesale and brokered deposits, promising 'low levels going forward'. Contradicting this narrative, brokered deposits spiked 25% sequentially in 26Q1, from $435.7M to $548.1M. This suggests domestic organic deposit generation is struggling to keep pace with funding needs.
Credit Quality: The Long Tail of Bad Loans
The asset quality cleanup is stable but remains heavily elevated. Total Non-Performing Assets increased to $191.6M (1.93% of total assets). While management successfully reduced Classified loans by 9.7% to $320.3M through payoffs and sales, Special Mention loans sneaked up 8.6% to $148.2M due to new downgrades, forcing the provision for credit losses to double sequentially to $7.8M.
FIS Technology Implementation Yielding Results
Following the core conversion to the new FIS technology framework mentioned in prior quarters, the bank is successfully leveraging technology to drive down telecommunications, data processing, and back-office staffing costs. Total FTEs are down to 699, holding steady while maintaining a $9.9B asset base.
Macro Tailwind: Venezuela Economic Reactivation
Amerant continues to benefit uniquely from international deposits. Venezuelan deposits now total $2.0B (up from $1.9B in 25Q4), comprising the bulk of their $2.7B foreign deposit base. The cost of these international deposits is incredibly low at 1.04%, buffering the bank against the 3.00% cost of domestic funding.
Proactive Portfolio Monitoring
Management restructured their credit oversight by establishing a dedicated Portfolio Management team, lowering the annual review threshold from $5M to $3M in credit exposure, and instituting quarterly 'Top 20' reviews. While this rigour is bringing more pain to the surface (Special Mention downgrades), it prevents future surprises.
Other KPIs
Reversing positively from a dismal $5.4M in 25Q4. However, it remains below the $33-35M range seen in 25Q1-25Q3, indicating that while the bleeding has stopped, the core operating engine is generating less cash than it did a year ago.
Stable sequentially (up just 0.8%). The bank continues to intentionally suppress loan origination volume to focus on exiting criticized out-of-footprint exposures. Consumer and CRE balances remain essentially flat.
Guidance
Decelerating. A steep decline from 26Q1's 3.55% and 25Q4's 3.78%. Management expects it to stabilize around 3.40% toward the end of 2026. This confirms that the top-line revenue pain is not over.
Accelerating from the current flatline. After intentionally shrinking the book in late 2025 and 26Q1, management projects total loans will reach $7 billion by 26Q2. This will require a significant pivot from defense to offense in originations.
Stable. Up slightly from 26Q1's $66.9M, but representing a sustainable run-rate compared to the bloated >$75M quarters of mid-2025. Management is targeting a 60% efficiency ratio long-term.
Key Questions
Brokered Deposit Reversal
Last quarter, leadership stated the reduction in brokered deposits was intentional to optimize the balance sheet. Yet, brokered deposits grew by $112M this quarter. What drove this sudden reversal in funding strategy?
NIM Floor Expectations
With NIM guided down to 3.40% by year-end, what interest rate environment is baked into this assumption? If the Fed pauses cuts, does NIM compress further, or is this the absolute floor?
Special Mention Downgrades
Special mention loans increased by $11.8 million despite aggressive offloading. Are these new downgrades coming from the Commercial or CRE book, and what percentage of the $3M+ exposure reviews are now complete?
Loan Growth Execution
You are guiding for ~7% loan growth in 2026 after multiple quarters of contraction. Given your tightened underwriting and recalibrated risk appetite, where exactly will this new loan volume come from geographically and by sector?